Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Virus or bacteriophage
Reexamination Certificate
2011-01-11
2011-01-11
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Virus or bacteriophage
C514S879000
Reexamination Certificate
active
07867487
ABSTRACT:
Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits.
REFERENCES:
patent: 03059386 (2003-07-01), None
Molenaar et al. Uptake and Processing of Modified Bacteriophage M13 in Mice: Implilcations for Phage Display. Virology, 2002, vol. 293, pp. 182-191.
Banks WA and Kastin AJ, “Bidirectional passage of peptides across the blood-brain barrier” Progress in Brain Research, 91:139-148 (1992).
Bard et al., “Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease” Nat. Med., 6:916-919 (2000).
Caughey et al., “Secondary Structure Analysis of the Scrapie-Associated Protein PrP 27-30 in Water by Infrared Spectroscopy”, Biochemistry, 30:7672-7680 (1991).
Chartier et al., “Early-Onset Alzheimer's Disease Caused by Mutations at Codon 717 of the β-amyloid precursor protein gene”, Nature, 353:844-846 (1991).
Chou KJ and Donovan MD, “Distribution of Antihistamines Into the CSF Following Intranasal Delivery”, Biopharm Drug Dispos., 18:335-346 (1997).
De Gioia et al, “Conformational Polymorphism of the Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion Protein” J. Biol Chem., 269:7859-7862 (1994).
Draghia et al., “Gene delivery into the central nervous system by nasal instillation in rats”, Gene Therapy, 2:418-423 (1995).
Forloni et al., “Neurotoxicity of a prion protein fragment”, Nature, 362:543-546 (1993).
Frenkel et al., “N-terminal EFRH sequence of Alzheimer's b-amyloid peptide represents the epitope of its anti-aggregating antibodies”, Journal of Neuroimmunology, 88:85-90 (1998).
Frenkel D and Solomon B, “Filamentous phage as vector-mediated antibody delivery to the brain”, PNAS, 99:5675-5679 (2002).
Gajdusek, D.C., “Unconventional Viruses and the Origin and Disappearance of Kuru”, Science, 197:943-960 (1977).
Gazit, E, “Mechanistic Studies of the Process of Amyloid Fibrils Formation by the Use of Peptide Fragments and Analogues: Implications for the Design of Fibrillization Inhibitors”, Curr. Med. Chem., 9:1725-1735 (2002).
Goate et al., “Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with familial Alzheimer's disease”, Nature, 349:704-706 (1991).
Greenwood et al., “Multiple Display of Foreign Peptides on a Filamentous Bacteriophage”, J. Mol. Biol., 220:821-827 (1991).
Griffith et al., “Filamentous Bacteriophage Contract into Hollow Spherical Particles upon Exposure to a Chloroform-Water Interface”, Cell, 23:747-753 (1981).
Hardy, J., “Amyloid, the presenilins and Alzheimer's disease”, TINS, 20:154-159 (1997).
Hart et al., “Cell Binding and Internalization by Filamentous Phage Displaying a Cyclic Arg-Gly-Asp-containing Peptide”, J. Biol Chem., 269:12468-12474 (1994).
Horiuchi M and Caughey B., “Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state”, EMBO J., 18:3193-3203 (1999).
Kanyo et al., “Antibody Binding Defines a Structure for an Epitope that Participates in the PrPC→PrPSc Conformational Change”, J. Mol. Biol., 293:855-863 (1999).
LeVine H., “Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution”, Protein Science, 2:404-410 (1993).
Lin et al., “Selection of Specific Phage from Display Libraries: Monoclonal Antibody Against VCS M13 Helper Phage Coat Protein III (gIIIp)”, Hybridoma, 18:257-261 (1999).
Maggio JE and Mantyh PW, “Brain Amyloid—A Physicochemical Perspective”, Brain Pathology, 6:147-162 (1996).
Marvin DA and Hale RD , “Molecular Models and Structural Comparisons of Native and Mutant Class I Filamentous Bacteriophages Ff (fd, f1, M13), If1 and IKe”, J. Mol. Biol., 235:260-286 (1994).
Marvin DA, “Filamentous phage structure, infection and assembly”, Current Opinion in Structural Biology, 8:105-158 (1998).
Mathison et al., “Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?”, J. Drug Target, 5:415-441 (1998).
McCafferty et al., “Phage Antibodies: Filamentous Phage Displaying Antibody Variable Domains”, Nature, 348:552-554.
Medori et al., “Fatal Familial Insomnia, A Prion Disease With a Mutation at Codon 178 of the Prion Protein Gene”, N. Engl. J. Med., 326:444-449 (1992).
Monaci et al., “Phage as gene delivery vectors”, Curr. Opin. Mol. Ther., 3:159-169 (2001).
Mullan et al., “Apathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid”, Nature Genet, 1:345-347 (1992).
Murrell et al., “A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease”, Science, 254:97-101 (1991).
Pan et al., “Conversion of a-helices into β-sheets features in the formation of the scrapie prion proteins”, PNAS USA, 90:10962-10966 (1993).
Peretz et al. “A Conformational Transition at the N Terminus of the Prion Protein Features in Formation of the Scrapie Isoform”, J. Mol. Biol., 273:614-622 (1997).
Pike et al., “Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro”, J. Biol. Chem., 270:23895-23898 (1995).
Roberts LM and Dunker AK, “Structural Changes Accompanying Chloroform-Induced Contraction of the Filamentous Phage fd”, Biochemistry, 32:10479-10488 (1993).
Rodi DJ and Makowski L, “Phage-display technology—finding a needle in a vast molecular haystack”, Current Opinion in Biotechnology, 10:87-93 (1999).
Scott JK and SMith GP, “Searching for peptide ligands with an epitope library”, Science, 249:386-639 (1990).
Selvaggini et al., “Molecular Characteristics of a Protease-Resistant, Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion Protein”, Biochem. Biophys. Res. Comm., 1994:1380-1386 (1993).
Silen JL and Agard DA, “The α-lytic protease pro-region does not require a physical linkage to activate the protease domain in vivo”, Nature, 341:462-464 (1989).
Solomon et al., “Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide”, PNAS USA, 93:452-455 (1996).
Solomon et al., “Disaggregation of Alzheimer β-amyloid by site-directed mAb”, PNAS USA, 94:4109-4112 (1997).
Tagliavini et al., “Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro”, PNAS USA, 90:9678-9682 (1993).
Wilesmith DR and Wells GAH, “Bovine Spongiform Encephalopathy”, Curr. Top. Microbiol. Immunol., 172:21-38 (1991).
Wilson DR and Finlay BB, “Phage display: Applications, innovations, and issues in phage and host biology”, Can J. Microbiol., 44:313-329 (1998).
Young et al., “Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat: Evidence for a metabolic role of endogenous amylin”, FEBS Lett., 343:237-241 (1994).
Lichtlen et al., Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools, J. Neurochem. 104:859-874 (2008).
Games et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature 373:523-527 (1995).
Holmes et al., Long-term effects of Aβ42 in immunisation in Alzheimer's d
Goren Orna
Solomon Beka
Browdy and Neimark PLLC
Crouch Deborah
Ramot at Tel-Aviv University Ltd.
LandOfFree
Method for treating inflammation associated with amyloid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating inflammation associated with amyloid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating inflammation associated with amyloid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2642566